On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors
暂无分享,去创建一个
Ola Engkvist | Lars Brive | Hongming Chen | Mari Hansson | John Pemberton | Isabella Feierberg | Philip Jarvis | Linda Zander-Balderud
[1] Stuart Barber,et al. All of Statistics: a Concise Course in Statistical Inference , 2005 .
[2] A. Fliri,et al. Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.
[4] J. Peters,et al. Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds , 2009, ChemMedChem.
[5] A. Bender,et al. Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data , 2007, ChemMedChem.
[6] Stephen D Pickett,et al. The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. , 2011, Drug discovery today.
[7] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.
[8] Stephen J. Wright,et al. Numerical Optimization , 2018, Fundamental Statistical Inference.
[9] S. Muresan,et al. Investigation of the relationship between topology and selectivity for druglike molecules. , 2010, Journal of medicinal chemistry.
[10] Paul D. Leeson,et al. Impact of ion class and time on oral drug molecular properties , 2011 .
[11] T. Ritchie,et al. The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.
[12] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[13] Wolfgang Guba,et al. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.
[14] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[15] Larry Wasserman,et al. All of Statistics , 2004 .
[16] Alan Stobie,et al. Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity. , 2008, Bioorganic & medicinal chemistry letters.
[17] F. Lovering,et al. Escape from Flatland 2: complexity and promiscuity , 2013 .
[18] D. Bojanic,et al. Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.
[19] David J Diller,et al. Deriving knowledge through data mining high-throughput screening data. , 2004, Journal of medicinal chemistry.
[20] D. Horvath,et al. G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation. , 2005, Journal of medicinal chemistry.